Protein kinase A as a biological target in cancer therapy

Expert Opin Ther Targets. 2009 Jan;13(1):83-92. doi: 10.1517/14728220802602349.

Abstract

Background: cAMP is a second messenger that plays a role in intracellular signal transduction of various stimuli. a major function of cAMP in eukaryotes is activation of cAMP-dependent protein kinase (PKA). PKA is the best understood member of the serine-threonine protein kinase superfamily, and is involved in the control of a variety of cellular processes. since it has been implicated in the initiation and progression of many tumors, PKA has been suggested as a novel molecular target for cancer therapy.

Objective/methods: Here, after describing some features of cAMP/PKA signaling that are relevant to cancer biology, we review targeting of PKA in cancer therapy, also discussing PKA as a biomarker for cancer detection and monitoring of therapy.

Results/conclusions: PKA is an increasingly relevant biological target in the therapy and management of cancer.

Publication types

  • Review

MeSH terms

  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors*
  • Humans
  • Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Signal Transduction

Substances

  • Protein Kinase Inhibitors
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases